CA2015077A1 - Levure du genre schwanniomyces - Google Patents

Levure du genre schwanniomyces

Info

Publication number
CA2015077A1
CA2015077A1 CA2015077A CA2015077A CA2015077A1 CA 2015077 A1 CA2015077 A1 CA 2015077A1 CA 2015077 A CA2015077 A CA 2015077A CA 2015077 A CA2015077 A CA 2015077A CA 2015077 A1 CA2015077 A1 CA 2015077A1
Authority
CA
Canada
Prior art keywords
dna sequence
yeast cell
genus schwanniomyces
expression
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015077A
Other languages
English (en)
Other versions
CA2015077C (fr
Inventor
Cornelius P. Hollenberg
Alexander Strasser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynavax GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2015077A1 publication Critical patent/CA2015077A1/fr
Application granted granted Critical
Publication of CA2015077C publication Critical patent/CA2015077C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
CA002015077A 1989-04-28 1990-04-20 Levure du genre schwanniomyces Expired - Fee Related CA2015077C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89107780A EP0394538B1 (fr) 1989-04-28 1989-04-28 Cellules de levure du genre schwanniomyces
DE89107780.2 1989-04-28

Publications (2)

Publication Number Publication Date
CA2015077A1 true CA2015077A1 (fr) 1990-10-28
CA2015077C CA2015077C (fr) 2000-07-25

Family

ID=8201308

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015077A Expired - Fee Related CA2015077C (fr) 1989-04-28 1990-04-20 Levure du genre schwanniomyces

Country Status (7)

Country Link
EP (1) EP0394538B1 (fr)
JP (1) JPH03143385A (fr)
AT (1) ATE144281T1 (fr)
CA (1) CA2015077C (fr)
DE (2) DE394538T1 (fr)
ES (1) ES2038579T3 (fr)
GR (2) GR910300058T1 (fr)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786257B1 (fr) 1992-06-03 2003-07-30 Genentech, Inc. Variantes d'activateur de plasminogène tissulaire obtenues par glycosylation, presentant de meilleures propriétés thérapeutiques
EP1382679A3 (fr) 1995-09-08 2004-11-10 Genentech, Inc. Antagonists du proteine apparentee a facteur de croissance endothelial vasculaire (VRP)
EP0885299B1 (fr) 1996-01-08 2005-10-26 Genentech, Inc. Recepteur et ligands ob
US6159462A (en) * 1996-08-16 2000-12-12 Genentech, Inc. Uses of Wnt polypeptides
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
WO1999021999A2 (fr) 1997-10-29 1999-05-06 Genentech, Inc. Polypeptides et acides nucleiques les codant
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
US6387657B1 (en) 1997-10-29 2002-05-14 Genentech, Inc. WISP polypeptides and nucleic acids encoding same
EP2050762A3 (fr) 1998-03-10 2009-07-08 Genentech, Inc. Nouvelles polypeptides et acides nucléiques les codant
EP1865061A3 (fr) 1998-05-15 2007-12-19 Genentech, Inc. Polypeptides allogéniques IL-17 et utilisations thérapeutiques
EP3112468A1 (fr) 1998-05-15 2017-01-04 Genentech, Inc. Polypeptides allogéniques il-17 et utilisations thérapeutiques
DE69936382T3 (de) 1998-05-15 2011-07-07 Genentech, Inc., Calif. Therapeutische verwendungen von il-17 homologe polypeptide
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
EP2075335A3 (fr) 1998-12-22 2009-09-30 Genentech, Inc. Procédés et compositions d'inhibition de la croissance de cellules néoplasiques
DE60043322D1 (de) 1999-06-15 2009-12-24 Genentech Inc Sekretierte und Transmembran-Polypeptide sowie Nukleinsäuren zu deren Kodierung
CA2491610A1 (fr) 1999-12-01 2001-06-07 Kevin P. Baker Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
DK1897944T3 (da) 1999-12-23 2011-10-24 Genentech Inc IL-17 homologe polypeptider og terapeutisk anvendelse deraf
DE60137829D1 (de) 2000-01-13 2009-04-16 Genentech Inc Menschliche stra6 polypeptide
CA2648046A1 (fr) 2000-06-23 2002-01-03 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
EP2275549A1 (fr) 2000-06-23 2011-01-19 Genentech, Inc. Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogénèse
ATE412009T1 (de) 2000-08-24 2008-11-15 Genentech Inc Methode zur inhibierung von il-22 induziertem pap1
EP1944317A3 (fr) 2000-09-01 2008-09-17 Genentech, Inc. Polypeptides sécrétés et transmembranaires, et acides nucléiques les codant
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
KR100788092B1 (ko) 2001-06-20 2007-12-21 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
CN101884784B (zh) 2001-08-29 2014-03-12 杰南技术公司 具有促细胞分裂活性的Bv8的核酸和多肽
DE60238143D1 (de) 2001-09-18 2010-12-09 Genentech Inc Zusammensetzungen und verfahren für die diagnose von tumoren
CN101724075B (zh) 2001-10-10 2014-04-30 诺和诺德公司 肽的重构和糖缀合
EP2298354B1 (fr) 2001-10-10 2014-03-19 ratiopharm GmbH Remodelage et glycoconjugation de Intérferon-beta
MXPA04006554A (es) 2002-01-02 2005-03-31 Genentech Inc Composiciones y metodos para diagnostico y tratamiento de tumor.
JP2005535290A (ja) 2002-02-22 2005-11-24 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
EP2011886A3 (fr) 2002-04-16 2009-02-11 Genentech, Inc. Compositions et procédés pour le traitement et le diagnostic d'une tumeur
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques
WO2003103725A1 (fr) 2002-06-07 2003-12-18 Genentech, Inc. Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
WO2004004649A2 (fr) 2002-07-08 2004-01-15 Genentech, Inc. Compositions et procedes destines au traitement de maladies liees au systeme immunitaire
WO2004024068A2 (fr) 2002-09-11 2004-03-25 Genentech, Inc. Nouvelles composition et methodes servant au traitement de maladies associees au systeme immunitaire
WO2004024072A2 (fr) 2002-09-11 2004-03-25 Genentech, Inc. Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire
AU2003255988A1 (en) * 2002-09-13 2004-04-30 Edupuganti B. Raju Yeast protein expression secretion system
JP2006515165A (ja) 2002-09-16 2006-05-25 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
WO2004028479A2 (fr) 2002-09-25 2004-04-08 Genentech, Inc. Nouvelles compositions et methodes de traitement du psoriasis
JP2006517785A (ja) 2002-10-29 2006-08-03 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
AU2003295401B2 (en) 2002-11-08 2010-04-29 Genentech, Inc. Compositions and methods for the treatment of natural killer cell related diseases
WO2004047728A2 (fr) 2002-11-26 2004-06-10 Genentech, Inc. Compositions et procedes destines au traitement de maladies de nature immune
AU2004205684A1 (en) 2003-01-23 2004-08-05 Genentech, Inc. Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
MXPA05009743A (es) 2003-03-12 2006-03-09 Genentech Inc Composiciones con actividad hematopoyetica e inmune.
JP4869064B2 (ja) 2003-04-04 2012-02-01 ジェネンテック， インコーポレイテッド 高濃度抗体及びタンパク質製剤
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
AU2004251145C1 (en) 2003-06-12 2011-04-14 Eli Lilly And Company GLP-1 analog fusion proteins
KR100945327B1 (ko) 2003-07-08 2010-03-08 제넨테크, 인크. Ｉｌ-１７ａ／ｆ 이종 폴리펩티드 및 그의 치료 용도
WO2005019258A2 (fr) 2003-08-11 2005-03-03 Genentech, Inc. Compositions et methodes de traitement de maladies relatives au systeme immunitaire
EP2412725A3 (fr) 2003-11-17 2012-04-25 Genentech, Inc. Anticorps contre le CD79b pour le traitement de tumeurs d'origine hématopoïétique
JP2008541781A (ja) 2005-06-06 2008-11-27 ジェネンテック・インコーポレーテッド 異なる遺伝子に対するトランスジェニック動物、および遺伝子の特徴づけのためのその使用
JP2009504183A (ja) 2005-08-15 2009-02-05 ジェネンテック・インコーポレーテッド 遺伝子破壊、それに関連する組成物および方法
CA2630432A1 (fr) 2005-11-21 2007-07-19 Genentech, Inc. Nouvelles dissociations de genes, compositions et procedes les concernant
WO2007114979A2 (fr) 2006-02-17 2007-10-11 Genentech, Inc. Nouvelles disruption géniques, compositions et procédés associés
EP2004221A2 (fr) 2006-03-23 2008-12-24 Novartis Pharma AG Thérapeutique anticorps antigène de cellules anti-tumorales
AU2007243946B2 (en) 2006-04-05 2012-11-29 Curis, Inc. Method for using BOC/CDO to modulate hedgehog signaling
US20090288176A1 (en) 2006-04-19 2009-11-19 Genentech, Inc. Novel Gene Disruptions, Compositions and Methods Relating Thereto
AU2007249160B2 (en) 2006-05-15 2013-09-12 I2 Pharmaceuticals, Inc. Neutralizing antibodies to influenza viruses
EP2826788B1 (fr) 2006-06-21 2017-12-13 MUSC Foundation for Research Development Ciblage de facteur h du complément pour le traitement de maladies utilisant des molecules cr2-fh
MX2009004664A (es) 2006-11-02 2009-10-12 Daniel J Capon Inmunoglobulinas hibridas con partes moviles.
CA2676790A1 (fr) 2007-02-22 2008-08-28 Genentech, Inc. Methode de detection d'une maladie intestinale inflammatoire
DK3597659T3 (da) 2007-07-09 2023-04-03 Genentech Inc Forhindring af disulfidbindingsreduktion under rekombinant produktion af polypeptider
EP2641618A3 (fr) 2007-07-16 2013-10-23 Genentech, Inc. Anticorps anti-CD79B humanisés et immuno-conjugués et procédés dýutilisation
SG183023A1 (en) 2007-07-16 2012-08-30 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
CN101361968B (zh) 2007-08-06 2011-08-03 健能隆医药技术（上海）有限公司 白介素-22在治疗脂肪肝中的应用
IL295449A (en) 2008-01-31 2022-10-01 Genentech Inc and fusion antibody-drug-cd79b engineered antibodies cysteine-
AU2009228058A1 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
HUE036780T2 (hu) 2008-04-09 2018-07-30 Genentech Inc Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére
US8937046B2 (en) 2008-09-22 2015-01-20 The Regents Of The University Of Colorado, A Body Corporate Modulating the alternative complement pathway
CN102348715B (zh) 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
PE20120878A1 (es) 2009-04-01 2012-08-06 Genentech Inc ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS
WO2010144508A1 (fr) 2009-06-08 2010-12-16 Amunix Operating Inc. Polypeptides de régulation du glucose et leurs procédés de production et d'utilisation
NZ596787A (en) 2009-06-08 2014-03-28 Amunix Operating Inc Growth hormone polypeptides and methods of making and using same
MX368790B (es) 2009-10-15 2019-10-16 Genentech Inc Factores de crecimiento de fibroblasto quimericos con especificidad de receptor alterada.
RU2539772C2 (ru) 2009-10-22 2015-01-27 Дженентек, Инк. Способы и композиции для модуляции гепсином стимулирующего макрофаги белка
WO2011056502A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Compositions du gene recepteur de proteine morphogenetique osseuse type ii et procedes d'utilisation
WO2011056497A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Compositions de récepteur de l'activine de type iib et leurs méthodes d'utilisation
WO2011056494A1 (fr) 2009-10-26 2011-05-12 Genentech, Inc. Combinaisons d'antagonistes de la kinase-1 du type récepteur de l'activine et d'antagonistes vegfr3
TW201121570A (en) 2009-11-12 2011-07-01 Genentech Inc A method of promoting dendritic spine density
CN103755809B (zh) 2009-11-30 2016-06-01 霍夫曼-拉罗奇有限公司 治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
AR080243A1 (es) 2010-02-23 2012-03-21 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
SG185027A1 (en) 2010-05-03 2012-11-29 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
KR101768118B1 (ko) 2010-06-25 2017-08-14 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 기도 감염의 치료를 위한 방법 및 약학 조성물
CN102380091A (zh) 2010-08-31 2012-03-21 健能隆医药技术（上海）有限公司 白介素-22在治疗病毒性肝炎中的应用
CN103797026A (zh) 2010-09-15 2014-05-14 阿利吉那科技有限公司 由木质素衍生的化合物生物生产芳香族化学品
EP2640831A1 (fr) 2010-11-17 2013-09-25 Sea Lane Biotechnologies,llc. Agents de neutralisation du virus de la grippe qui imitent le site de liaison d'un anticorps de neutralisation du virus de la grippe
ES2759061T3 (es) 2013-03-15 2020-05-07 Biomolecular Holdings Llc Inmunoglobulina híbrida que contiene unión no peptidílica
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2015116902A1 (fr) 2014-01-31 2015-08-06 Genentech, Inc. Récepteurs couplés aux protéines g dans la signalisation hedgehog
NZ724904A (en) 2014-03-14 2023-04-28 Biomolecular Holdings Llc Hybrid immunoglobulin containing non-peptidyl linkage
EP3442562B1 (fr) 2016-04-15 2022-09-21 Evive Biotechnology (Shanghai) Ltd Un dimère il-22 pour l'utilisation dans le traitement de l'entérocolite nécrosante
US11007254B2 (en) 2016-10-17 2021-05-18 Musc Foundation For Research Development Compositions and methods for treating central nervous system injury
WO2018152496A1 (fr) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions et méthodes de diagnostic et de traitement de l'infection par le virus zika
EP3615569A1 (fr) 2017-04-25 2020-03-04 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Anticorps et procédés de diagnostic et de traitement d'infection par le virus d'epstein barr
WO2019018629A1 (fr) 2017-07-19 2019-01-24 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Anticorps et procédés de diagnostic et de traitement d'infection par le virus de l'hépatite b
CN107653261A (zh) * 2017-10-19 2018-02-02 昆明理工大学 利用啤酒酵母MF‑α介导重组蛋白分泌的植物表达载体
WO2019089544A1 (fr) 2017-11-01 2019-05-09 Tufts Medical Center, Inc. Constructions d'anticorps bispécifiques et procédés d'utilisation
EP3788071A1 (fr) 2018-05-02 2021-03-10 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Anticorps et méthodes de diagnostic, de prévention et de traitement d'infection par le virus d'epstein barr
KR20230002559A (ko) 2020-04-15 2023-01-05 제넨테크, 인크. 구리 손실 완화

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82935A0 (en) * 1986-08-12 1987-12-20 Phillips Petroleum Co Secretion of heterologous proteins from yeast
EP0257115A1 (fr) * 1986-08-21 1988-03-02 Heineken Technisch Beheer B.V. Micro-organismes produisant des enzymes amylolytiques et construits par la technologie des ADN recombinants et leur utilisation dans des procédés de fermentation
EP0260404B1 (fr) * 1986-08-21 1995-05-31 VAN DEN BERG, Robert Microorganismes produisant des enzymes amylolytiques construits par la technologie des ADN recombinants et leur utilisation dans des procédés de fermentation

Also Published As

Publication number Publication date
GR3022124T3 (en) 1997-03-31
EP0394538A1 (fr) 1990-10-31
CA2015077C (fr) 2000-07-25
DE68927344D1 (de) 1996-11-21
ES2038579T3 (es) 1997-02-16
EP0394538B1 (fr) 1996-10-16
DE394538T1 (de) 1991-04-11
DE68927344T2 (de) 1997-02-20
ES2038579T1 (es) 1993-08-01
ATE144281T1 (de) 1996-11-15
GR910300058T1 (en) 1991-11-15
JPH03143385A (ja) 1991-06-18

Similar Documents

Publication Publication Date Title
CA2015077A1 (fr) Levure du genre schwanniomyces
CA2263889A1 (fr) Proteines ligands de p-selectine
EP1688500A3 (fr) Surexpression de la Phytase dans la levure
DE69333766D1 (de) Herstellung von phytat-degradierenden enzymen in trichoderma
CA2123107A1 (fr) Proteases specifiques de l'ubiquitine
WO1999012968A3 (fr) Peptides de chemokines, variants, derives et analogues. leur utilisation dans des procedes pour inhiber ou renforcer une reaction inflammatoire
CA2315274A1 (fr) Polypeptides a activite aminopeptidase, et acides nucleiques codant ces polypeptides
WO1997008325A3 (fr) Laccases de coprin purifiees et acides nucleiques les codant
CA2170509A1 (fr) Adn codant le recepteur ep2 de la prostaglandine
AU3802595A (en) Tripeptidyl aminopeptidase
AU581455B2 (en) New peptides with angiotensin converting enzyme inhibitory activity
CA2497857A1 (fr) Nouveau coordinat proteinique de type p-selectine
AU3069584A (en) Peptides, pharmaceutical compositions,genes,vectors,host organisms, processes for there production and diagnostic reagents
AU615413B2 (en) Production of thrombin inhibitors
AU621810B2 (en) Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for fermentation processes
WO1996041868A3 (fr) Derives de prothrombine
WO1995032731A3 (fr) Produits pharmaceutiques immunogenes
CA2163755A1 (fr) Adn codant le recepteur ep1 de la prostaglandine
WO1995030001A3 (fr) Nouvelle proteine ligand de p-selectine
EP0320806A3 (fr) Gène lié à l'activation des cellules T
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
CA2159079A1 (fr) Methodes et systemes d'expression de l'adn, utilises pour la surexpression de proteines dans des cellules hotes
AU3107684A (en) Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production
CA2245584A1 (fr) Expression par recombinaison de proteines de couche superficielle
WO1998029438A3 (fr) Polypeptides de cortistatine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed